160 results on '"Couture, Larry"'
Search Results
2. Design and Operation of a Multiuse GMP Facility at the City of Hope
3. Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.
4. Application of the Suspension Culture System for Scale-Up Manufacture of hPSCs and hPSC-Derived Cardiomyocytes
5. Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates
6. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells
7. Completing a doctoral dissertation during a global pandemic: Lessons learned.
8. Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation
9. Erratum: Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
10. Epigenetic stability, adaptability, and reversibility in human embryonic stem cells
11. Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
12. Scalable GMP compliant suspension culture system for human ES cells
13. Erratum: Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates
14. Hurdles to clinical translation of human induced pluripotent stem cells
15. Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program
16. The Suspension Culture of Undifferentiated Human Pluripotent Stem Cells Using Spinner Flasks
17. GMP Scale-Up and Banking of Pluripotent Stem Cells for Cellular Therapy Applications
18. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)
19. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies
20. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
21. Adenoviral-mediated Gene Transfer to Fetal Pulmonary Epithelia In Vitro and In Vivo
22. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling
23. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair
24. 244. Development and Qualification of Assays for Human Embryonic Stem Cell (hESC)-Derived Cardiomyocytes Intended for Clinical Use
25. Mapping Human Pluripotent-to-Cardiomyocyte Differentiation: Methylomes, Transcriptomes, and Exon DNA Methylation “Memories”
26. 2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development
27. 661. Assay Development and Qualification for Human Embryonic Stem Cell (hESC)-Derived Cardiomyocytes Intended for Clinical Studies
28. 193. Establishment of an Optimization Procedure for Large-Scale Production of Patient-Specific Cardiomyocytes from hiPSCs
29. 606. cGMP Compliant Process to Produce Day-14 Transplantable Dopaminergic Neuron Precursors
30. Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program
31. Ribozyme-Mediated Inhibition of Cell Proliferation: A Model for Identifying and Refining a Therapeutic Ribozyme
32. Surveying the best in translation
33. An Update from the United States National Heart, Lung, and Blood Institute‐funded Production Assistance for Cellular Therapies (PACT) Program: A Decade of Cell Therapy
34. Optimizing the production of suspension cells using the G-Rex “M” series
35. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling
36. The Suspension Culture of Undifferentiated Human Pluripotent Stem Cells Using Spinner Flasks.
37. Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies
38. Pluripotent stem cells for Parkinson's disease: progress and challenges
39. Replication-competent Lentivirus Analysis of Clinical Grade Vector Products
40. RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34 + Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
41. Scalable pluripotent stem cell culture
42. Purity, Potency and Safety: Quality Management Reports (QMR) as the Basis for An Effective Continuous Process Improvement System in An Academic Gene Therapy Program.
43. Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms
44. First in Human Engraftment of Anti-HIV Lentiviral Vector Gene Modified CD34+ Peripheral Blood Progenitor Cells in the Treatment of AIDS Related Lymphoma (ARL).
45. Autologous Stem Cell Transplantation (ASCT) for AIDS-Related Lymphomas (ARL) and the Potential Role of HIV-Resistant Stem Cells.
46. Adenovirus-Mediated Expression of a Ribozyme to c- myb mRNA Inhibits Smooth Muscle Cell Proliferation and Neointima Formation In Vivo
47. Inhibition of Human Immunodeficiency Virus Type 1 by Tat/Rev-Regulated Expression of Cytosine Deaminase, Interferon alpha2, or Diphtheria Toxin Compared with Inhibition by Transdominant Rev
48. Choice words
49. Message Therapy: Gene Therapy That Targets mRNA Sequence and Stability
50. Anti-gene therapy: the use of ribozymes to inhibit gene function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.